189 related articles for article (PubMed ID: 8188384)
41. The future for vaccine development against Entamoeba histolytica.
Quach J; St-Pierre J; Chadee K
Hum Vaccin Immunother; 2014; 10(6):1514-21. PubMed ID: 24504133
[TBL] [Abstract][Full Text] [Related]
42. Elicitation of protective immunity to Entamoeba histolytica--an experimental study.
Nain PC; Vinayak VK
Immunol Cell Biol; 1987 Jun; 65 ( Pt 3)():217-22. PubMed ID: 2887509
[TBL] [Abstract][Full Text] [Related]
43. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
44. Immunogenicity and protective efficacy of heparan sulphate binding proteins of Entamoeba histolytica in a guinea pig model of intestinal amoebiasis.
Kaur U; Khurana S; Saikia UN; Dubey ML
Exp Parasitol; 2013 Nov; 135(3):486-96. PubMed ID: 24007700
[TBL] [Abstract][Full Text] [Related]
45. [Immunity in hamsters after vaccination with monoxenic acid axenic cultures of E. histolytica].
Sepúlveda B; Tanimoto-Weki M; Guerrero A; Solís G
Arch Invest Med (Mex); 1973; ():Suppl 1:159-64. PubMed ID: 4363314
[No Abstract] [Full Text] [Related]
46. Progress towards development of a vaccine for amebiasis.
Stanley SL
Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666
[TBL] [Abstract][Full Text] [Related]
47. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
[TBL] [Abstract][Full Text] [Related]
48. Entamoeba histolytica: antibody responses and lymphoreticular changes in gerbils (Meriones unguiculatus) in response to experimental liver abscess and amebic extract infection.
Chadee K; Meerovitch E
Z Parasitenkd; 1984; 70(6):781-95. PubMed ID: 6098090
[TBL] [Abstract][Full Text] [Related]
49. Immunoreactivities for Entamoeba histolytica in patients with amebic liver abscesses.
Avila EE; Liévano MA; Román M; Calderón J
Arch Invest Med (Mex); 1990; 21 Suppl 1():109-13. PubMed ID: 2136472
[TBL] [Abstract][Full Text] [Related]
50. Entamoeba histolytica: from adherence to enteropathy.
Ravdin JI
J Infect Dis; 1989 Mar; 159(3):420-9. PubMed ID: 2536786
[TBL] [Abstract][Full Text] [Related]
51. Vaccination against hepatic amebiasis in hamsters.
Ghadirian E; Meerovitch E
J Parasitol; 1978 Aug; 64(4):742-3. PubMed ID: 210268
[No Abstract] [Full Text] [Related]
52. Vaccines for amoebiasis: barriers and opportunities.
Stanley SL
Parasitology; 2006; 133 Suppl():S81-6. PubMed ID: 17274850
[TBL] [Abstract][Full Text] [Related]
53. Immunoprotective behaviour of plasma-membrane-associated antigens of axenic Entamoeba histolytica.
Vinayak VK; Purnima ; Saxena A
J Med Microbiol; 1987 Dec; 24(4):297-302. PubMed ID: 2891855
[TBL] [Abstract][Full Text] [Related]
54. [Immunogenicity of a delipidated antigen of Entamoeba histolytica].
Oliva A; Correa I; Ortiz-Ortiz L
Arch Invest Med (Mex); 1986; 17 Suppl 1():229-32. PubMed ID: 2884961
[No Abstract] [Full Text] [Related]
55. Host-antibody inductivity of virulent Entamoeba histolytica and non-virulent Entamoeba moshkovskii in a mouse model.
Khomkhum N; Leetachewa S; Pawestri AR; Moonsom S
Parasit Vectors; 2019 Mar; 12(1):101. PubMed ID: 30867040
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence.
Petri WA; Snodgrass TL; Jackson TF; Gathiram V; Simjee AE; Chadee K; Chapman MD
J Immunol; 1990 Jun; 144(12):4803-9. PubMed ID: 1693641
[TBL] [Abstract][Full Text] [Related]
57. Secretory immunoglobulin A antibodies to the galactose-inhibitable adherence protein in the saliva of patients with amebic liver disease.
Kelsall BL; Jackson TG; Gathiram V; Salig SB; Vaithilingum M; Pearson RD; Ravdin JI
Am J Trop Med Hyg; 1994 Oct; 51(4):454-9. PubMed ID: 7943572
[TBL] [Abstract][Full Text] [Related]
58. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
Carrero JC; Contreras-Rojas A; Sánchez-Hernández B; Petrosyan P; Bobes RJ; Ortiz-Ortiz L; Laclette JP
Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
[TBL] [Abstract][Full Text] [Related]
59. Entamoeba histolytica antigenic protein detected in pus aspirates from patients with amoebic liver abscess.
Othman N; Mohamed Z; Yahya MM; Leow VM; Lim BH; Noordin R
Exp Parasitol; 2013 Aug; 134(4):504-10. PubMed ID: 23680184
[TBL] [Abstract][Full Text] [Related]
60. Antigenic stability and immunodominance of the Gal/GalNAc adherence lectin of Entamoeba histolytica.
Petri WA; Broman J; Healy G; Quinn T; Ravdin JI
Am J Med Sci; 1989 Mar; 297(3):163-5. PubMed ID: 2538054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
